pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis

• 1. 一种制备治疗女性绝经后骨质疏松症的药物组合物的方法 [P] . 中国专利： CN105412587A . 2016-03-23
• 2. 一种治疗绝经后骨质疏松症的药物组合物及其制备方法 [P] . 中国专利： CN103550476B . 2015.09.16
• 3. PHARMACEUTICAL COMBINATION FOR THE PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS [P] . 欧洲知识产权局专利： EP0569415A1 . 1993-11-18

  机译： 药物组合预防和治疗绝经后骨质疏松症

• 4. PHARMACEUTICAL COMBINATION FOR THE PREVENTION AND TREATMENT¹OF POSTMENOPAUSAL OSTEOPOROSIS [P] . IE920219A1 . 1992-08-12

  机译： 预防和治疗绝经后骨质疏松症的药物组合¹

• 5. pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis [P] . ITMI910253A1 . 1992-08-02

  机译： 预防和治疗绝经后骨质疏松症的药物组合

• 1. Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women [J] . Yukio Nakamura, Takako Suzuki, Mikio Kamimura, 骨研究（英文版） . 2017,第002期
• 2. Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women [J] . Yukio Nakamura, Takako Suzuki, Mikio Kamimura, 骨研究：英文 . 2017,第002期
• 3. Intestinal microbiota:a potential target for the treatment of postmenopausal osteoporosis [J] . Xin Xu, Xiaoyue Jia, Longyi Mo, 骨研究（英文版） . 2017,第003期
• 4. Intestinal microbiota＂ a potential target for the treatment of postmenopausal osteoporosis [J] . Xin Xu, Xiaoyue Jia, Longyi Mo, 骨研究：英文 . 2017,第003期
• 5. COMPUTER SIMULATION-BASED MODELING OF THE PHARMACEUTICAL INTERVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY DENOSUMAB [C] . Stefan Scheiner, Peter Pivonka, David W. Smith, ASME biennial conference on engineering systems design and analysis . 2012
• 6. In-vivo studies of fullerene-bis(bisphosphonate) and synthesis of a fullerene-bisphosphonate-beta-blocker conjugate for the prevention and treatment of osteoporosis. [D] . Peralta, Ivana Romina Guadalupe. 2010
• 7. An Observational Study to Assess the Safety and Efficacy on Quality of Life and Patient Satisfaction With Raloxifene/Cholecalciferol Combination Therapy in Postmenopausal Women Requiring Prevention or Treatment for Osteoporosis [O] . Yoon-Sok Chung, Dong-Yun Lee 2021
• 8. An Observational Study to Assess the Safety and Efficacy on Quality of Life and Patient Satisfaction With Raloxifene/Cholecalciferol Combination Therapy in Postmenopausal Women Requiring Prevention or Treatment for Osteoporosis [O] . Yoon-Sok Chung, Dong-Yun Lee 2021

• 1. Curative Effect Analysis of Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis with Different Bone Turnover Rates [J] . Suming Jie ,Jinmei Deng ,Caixia Lin . 临床医学国际期刊（英文） . 2018,第8期
• 2. 针药结合对比电针组、药物组治疗绝经后骨质疏松症的临床疗效观察 [C] . 周志华 ,吴洲红 ,王乃权 . 2011浙江省针灸学会年会暨学术交流会 . 2011
• 3. 激素替代联合二磷酸盐预防和治疗绝经后骨质疏松症疗效的系统评价 [A] . 李鸣远 . 2009